Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cronos Australia Ltd. ( (AU:VIT) ) just unveiled an update.
Vitura Health Limited has announced the cessation of 137,979 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could affect stakeholder perceptions regarding the company’s ability to meet its performance targets.
The most recent analyst rating on (AU:VIT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Average Trading Volume: 249,576
Technical Sentiment Signal: Sell
Current Market Cap: A$42.38M
For an in-depth examination of VIT stock, go to TipRanks’ Overview page.